Michelle Blakely Wholehearted Holistic

24/07/2026

𝗠𝗘𝗡𝗢𝗣𝗔𝗨𝗦𝗘 𝗦𝗨𝗣𝗣𝗢𝗥𝗧👇
~ Article by Pete Wurst

Menopause has a reputation problem.

In conventional medicine, it is treated as a deficiency state — a decline to be managed, symptoms to be endured until they pass or suppressed with medication until the conversation can be closed.

In alternative wellness, it is reframed as a spiritual awakening — a transition into new power, a shedding of the reproductive self that should be embraced with gratitude and essential oils.

Neither of these serves women.

The first dismisses what is actually happening — real, measurable, biologically profound changes in every system of the body. Not just hot flashes and mood swings, but changes in the brain, heart, bones, gut, immune system, and metabolism that have genuine long-term health consequences.

The second romanticises a transition that is, for many women, genuinely hard — neurologically, emotionally, physically, and relationally — in ways that a spiritual reframe, however well-meaning, does not address and can actually silence.

Women deserve the truth. All of it.

🔬 𝐖𝐇𝐀𝐓 𝐌𝐄𝐍𝐎𝐏𝐀𝐔𝐒𝐄 𝐀𝐂𝐓𝐔𝐀𝐋𝐋𝐘 𝐈𝐒
Menopause is officially defined as 12 consecutive months without a menstrual period. It happens because the ovaries run out of eggs — and with that, they stop producing the hormones that have governed female biology since puberty.

The average age is 51, though anywhere from 45 to 55 is considered normal. Before age 40, it is called premature ovarian insufficiency.

What's actually changing hormonally — and it's more complex than most people realise:

Women are born with 1–2 million egg follicles. By puberty, that's down to around 400,000. Only 400–500 will ever release an egg. The rest gradually die off across the reproductive years. When the supply runs low enough that the ovaries can no longer respond to the brain's hormonal signals, the whole system begins to wind down.

But this doesn't happen overnight. The transition — called perimenopause — typically begins in the early-to-mid forties and can last 7–10 years before the final period arrives.

The key hormonal changes:

→ Progesterone falls first — often a decade before estrogen, starting in the mid-thirties; this early phase can feel like worsening PMS, heavier periods, breast tenderness, and mood instability — all signs of estrogen dominance before the estrogen itself starts dropping

→ Estrogen doesn't just decline — it becomes wildly unpredictable; in perimenopause, estradiol can swing from far-too-high to far-too-low within days; these fluctuations, not simply low estrogen, drive many of the most disruptive symptoms

→ FSH (follicle stimulating hormone) rises sharply — as the brain tries harder and harder to stimulate unresponsive ovaries; a persistently elevated FSH is the clinical marker that confirms the transition is underway

→ Testosterone and DHEA also decline — gradually through the forties and fifties, independently of menopause; this contributes to reduced libido, lower energy, loss of muscle mass, and a reduced overall sense of vitality

→ After menopause, the body's main estrogen source shifts — from the ovaries to fat tissue, which converts adrenal hormones into a weaker form of estrogen called estrone; this is significantly lower than premenopausal estradiol and lacks many of its biological properties

The three phases:

→ Perimenopause — the transition; typically 4–10 years of hormonal turbulence before the final period; often the most symptomatic phase
→ Menopause — technically just the moment of the final period, only recognisable in hindsight after 12 months with no period
→ Postmenopause — everything after; sustained low estrogen; the phase of greatest long-term health risk if the transition is not well-supported

⚡ 𝐖𝐇𝐀𝐓 𝐌𝐄𝐍𝐎𝐏𝐀𝐔𝐒𝐄 𝐃𝐎𝐄𝐒 𝐓𝐎 𝐄𝐕𝐄𝐑𝐘 𝐒𝐘𝐒𝐓𝐄𝐌 𝐈𝐍 𝐓𝐇𝐄 𝐁𝐎𝐃𝐘
Here is why the "it's just hot flashes" narrative is so inadequate.

Estrogen receptors are present in virtually every tissue in the human body. When estrogen declines, it affects not just the reproductive system but the brain, heart, bones, gut, immune system, joints, skin, and urinary tract. This is not a reproductive event. It is a whole-body event.

🔴 The brain — where menopause hits hardest and is most often dismissed

Estrogen is one of the most important neuroprotective hormones in the body. It supports neuron survival, memory formation, the production of serotonin and dopamine, and the energy supply to brain cells. When it declines, the brain feels it — and this is real neurology, not psychology.

→ Brain fog, word-finding difficulties, poor working memory, and slowed thinking are direct neurological consequences of estrogen withdrawal from brain tissue — not anxiety, not aging, not imagined

→ Depression and anxiety in menopause are not primarily emotional responses to getting older — they are the direct neurochemical result of estrogen withdrawal from the serotonin and GABA systems that regulate mood; the volatile estrogen of perimenopause creates corresponding mood volatility that tracks the hormonal swings

→ Hot flashes are brain events, not body events — the hypothalamus (the brain's thermostat) is destabilised by falling estrogen; it loses its ability to tolerate even small changes in body temperature without triggering a heat-dumping response; this is why the flash comes from within and why estrogen — which directly restores thermostat stability — is the most effective treatment

→ The Alzheimer's risk connection — research from Weill Cornell shows that the perimenopausal brain shows measurable reductions in energy metabolism even before symptoms appear; estrogen is a direct fuel regulator for neurons; its decline creates a metabolic vulnerability in the brain that, in susceptible women, may initiate the early stages of Alzheimer's pathology; this is not well-known, and it should be

→ The critical window — emerging research strongly suggests that estrogen's neuroprotective effects are most powerful when hormone therapy is started during or shortly after the menopausal transition; women who start estrogen more than a decade after menopause may not receive the same brain protection; timing matters enormously

🔴 The heart — the protection that quietly disappears

Before menopause, women have significantly lower rates of heart disease than men their age. Estrogen maintains the health and flexibility of blood vessel walls, supports good cholesterol, reduces LDL oxidation, and protects the heart directly.

After menopause, that protection is gone — and the cardiovascular risk rises sharply.

→ LDL cholesterol rises, HDL falls, triglycerides increase, and a particularly dangerous marker called lipoprotein(a) — which most doctors don't routinely test — rises significantly at menopause and stays elevated

→ Blood pressure rises as vascular stiffness increases — the hypertension that appears in many women in their fifties is significantly hormonal in origin, not simply age-related

→ Within 10 years of menopause, heart disease becomes the leading cause of death in women — far exceeding breast cancer, which women fear most; this fact is not communicated nearly enough

→ Visceral fat (the dangerous fat around the organs) accumulates, insulin resistance worsens, and the metabolic changes that drive heart disease accelerate; these are direct consequences of estrogen loss, not simply lifestyle

🔴 The bones — silent loss that starts earlier than most women know

Estrogen is the primary regulator of bone density throughout adult life. It keeps bone breakdown in check while allowing bone building to continue. When it falls, that balance tips — and bone loss accelerates dramatically.

→ In the first 5–10 years after menopause, bone loss averages 2–3% per year — far faster than at any other life stage

→ Osteoporosis affects around 30% of postmenopausal women; the fractures it causes — particularly hip and spine — are associated with loss of independence and significantly increased mortality

→ Bone loss begins in perimenopause — often 2–3 years before the final period; the window for prevention is earlier than most women are told

→ Once trabecular bone (the spongy inner bone of the spine and hip) is lost, it cannot be fully restored; prevention is far more effective than treatment

🔴 The urogenital system — the symptom most silently suffered

The va**na, v***a, and urinary tract are profoundly estrogen-dependent. When estrogen falls, these tissues thin, dry out, and lose their protective function — and unlike hot flashes, which typically resolve over a few years, these changes worsen progressively with time if left untreated.

This condition is called genitourinary syndrome of menopause (GSM) and it affects around 50–60% of postmenopausal women:

→ Vaginal dryness, pain during s*x, irritation, burning, and itching
→ Loss of the healthy va**nal microbiome — increasing vulnerability to bacterial infections and recurrent UTIs
→ Urinary urgency, frequency, leaking, and recurrent infections
→ These symptoms do not resolve on their own — they need treatment

The good news: local va**nal estrogen (cream, ring, or pessary) treats GSM effectively with negligible systemic absorption and is considered safe for virtually all women, including most breast cancer survivors.

🔴 The gut — where menopause is almost never discussed

Estrogen receptors line the entire gut. Estrogen influences gut motility, the integrity of the gut lining, and the composition of the gut microbiome. Its loss reshapes all three.

→ Bloating, irregular bowel function, and new food sensitivities frequently begin or worsen at menopause — they are hormonal, not coincidental
→ The gut microbiome shifts toward less diversity and more inflammation — which in turn affects mood, immunity, and how efficiently the body processes the small amounts of estrogen it still produces
→ The gut-brain axis changes correspondingly — contributing to the mood, anxiety, and cognitive symptoms of menopause through an indirect but significant pathway

🔴 Muscles, joints, and connective tissue

→ Muscle loss accelerates after menopause — because estrogen, testosterone, and growth hormone all supported muscle maintenance, and all are declining simultaneously; without active intervention, women lose significant muscle mass and strength in the post-menopausal years

→ Joint pain is one of the most common and least discussed menopausal symptoms — estrogen has anti-inflammatory effects in joints, cartilage, and ligaments; its loss drives joint stiffness and pain, particularly in the hands, knees, and hips; this is hormonal, not simply aging

→ Connective tissue becomes less elastic — estrogen supports collagen production; declining estrogen increases ligament laxity, injury risk, and pelvic floor weakness that contributes to urinary incontinence

→ Skin loses collagen rapidly — approximately 30% of dermal collagen is lost in the first 5 years after menopause

🔴 The immune system

→ The immune environment becomes measurably more inflammatory after menopause — inflammatory markers like hsCRP and IL-6 rise; this low-grade chronic inflammation is a primary driver of the accelerated cardiovascular, metabolic, and neurological risk of the post-menopausal years

→ Autoimmune conditions frequently change at menopause — rheumatoid arthritis often worsens; the hormonal-immune relationship is complex but real

😔 𝐓𝐇𝐄 𝐅𝐔𝐋𝐋 𝐒𝐘𝐌𝐏𝐓𝐎𝐌 𝐏𝐈𝐂𝐓𝐔𝐑𝐄
The breadth of menopausal symptoms is almost always underestimated — by practitioners, by women themselves, and by the culture at large.

Vasomotor (temperature regulation):
→ Hot flashes — affecting 80% of women; ranging from mild warmth to drenching sweats; unpredictable and socially disruptive
→ Night sweats — nocturnal hot flashes that shatter sleep; one of the most consequential menopausal symptoms because poor sleep cascades into worsened mood, cognition, metabolism, and immunity
→ Heart palpitations — common in perimenopause; usually benign but worth checking if new or severe

Neurological and psychological:
→ Brain fog — the most distressing symptom for many women; impaired memory, slow thinking, difficulty finding words; genuinely neurological, not imagined
→ Mood swings and irritability — partly serotonin-driven, partly the direct neurological effect of hormonal volatility, partly the entirely reasonable response to chronic sleep deprivation in a body that feels unfamiliar
→ Anxiety — frequently new-onset in perimenopause; driven by the loss of progesterone's calming GABA effects and estrogen's serotonin support
→ Depression — significantly more common in perimenopause; responds better to hormonal support than to antidepressants in this context for many women
→ Low mood and loss of pleasure — a pervasive flatness that isn't quite depression but is distinctly different from how life felt before
→ Sleep disruption — from night sweats, from progesterone loss removing natural sedative effects, from elevated cortisol; one of the most universal and most damaging menopausal symptoms

Musculoskeletal:
→ Joint pain and morning stiffness — particularly hands, knees, hips; often the first sign something hormonal is happening
→ Muscle aches and reduced exercise tolerance
→ Longer recovery after physical activity

Urogenital:
→ All the GSM symptoms above — dryness, discomfort, recurrent infections, urinary issues; the most consistently undertreated and most silently endured

Metabolic:
→ Weight gain — particularly around the middle; driven by declining estrogen, rising insulin resistance, and loss of muscle mass
→ Bloating and digestive changes
→ New food intolerances — particularly to histamine-rich foods, because estrogen fluctuation amplifies histamine reactivity

🔥 𝐖𝐇𝐀𝐓 𝐌𝐀𝐊𝐄𝐒 𝐌𝐄𝐍𝐎𝐏𝐀𝐔𝐒𝐄 𝐇𝐀𝐑𝐃𝐄𝐑 — 𝐀𝐍𝐃 𝐖𝐇𝐀𝐓 𝐌𝐀𝐊𝐄𝐒 𝐈𝐓 𝐄𝐀𝐒𝐈𝐄𝐑
Not all women experience menopause the same way. And the factors that determine how hard or how manageable the transition is are largely within reach.

What makes it harder:

→ Chronic stress — the single strongest predictor of severe menopausal symptoms; a dysregulated stress system amplifies hot flashes, worsens anxiety, destroys sleep, and enters the transition with depleted reserves; the body is already overwhelmed before the hormonal shift begins

→ Poor sleep — both a symptom and a driver; sleep deprivation worsens cortisol, insulin resistance, mood, cognition, and the emotional resilience needed to manage the transition

→ Insulin resistance and metabolic dysfunction — worsens every menopausal symptom; drives fat gain, inflammation, and hormonal imbalance simultaneously

→ Gut dysbiosis — impairs the body's ability to process and recycle even the small amounts of estrogen it still produces after menopause

→ Nutritional deficiencies — particularly magnesium, omega-3s, B vitamins, and vitamin D; each of these supports systems that estrogen no longer protects

→ Smoking — accelerates menopause by approximately 2 years and significantly worsens vasomotor symptoms

→ Surgical menopause (both ovaries removed) — produces immediate, abrupt, complete estrogen loss; far more severe than natural menopause; hormone therapy is strongly recommended in this situation for women under 51

What makes it easier:

→ Good metabolic health — women with healthy insulin sensitivity and lower inflammation consistently have milder symptoms; the health investments made in the thirties and forties pay dividends in the transition

→ A well-regulated nervous system — higher vagal tone directly stabilises the hypothalamic thermostat that drives hot flashes, reduces anxiety, and improves sleep; this is one of the most modifiable factors

→ Strength and muscle mass — women who enter menopause with more muscle have better metabolic resilience, better bone density, and better functional capacity throughout the transition and beyond

→ A healthy gut — better estrogen metabolism, better mood through the gut-brain axis, better immune resilience

→ Strong social connections — not a soft factor; the nervous system co-regulation of safe relationships directly moderates HPA axis dysregulation; women with strong social support consistently report milder symptoms

💊 𝐇𝐎𝐑𝐌𝐎𝐍𝐄 𝐓𝐇𝐄𝐑𝐀𝐏𝐘 — 𝐓𝐇𝐄 𝐇𝐎𝐍𝐄𝐒𝐓, 𝐂𝐎𝐌𝐏𝐋𝐄𝐓𝐄 𝐏𝐈𝐂𝐓𝐔𝐑𝐄
No discussion of menopause is complete without addressing hormone therapy honestly. And no topic in women's health has been more distorted by a single study.

The WHI study — what actually happened:

In 2002, a large clinical trial called the Women's Health Initiative was stopped early after finding increased rates of breast cancer, heart disease, stroke, and blood clots in women taking hormone therapy. The headlines that followed produced an immediate worldwide collapse in prescribing. Millions of women stopped treatment overnight. Symptoms went untreated for a generation.

But the headlines omitted critical context:

→ The study used synthetic hormones — conjugated equine estrogen (derived from horse urine) and a synthetic progestin called medroxyprogesterone acetate; these are not the same as the bioidentical estradiol and natural micronized progesterone used today, and their effects are not identical

→ The average participant was 63 years old — more than a decade past menopause; they were not perimenopausal women seeking relief from symptoms but older women with already-established cardiovascular changes; estrogen given to a 63-year-old with hardened arteries behaves differently from estrogen given to a 50-year-old during the active transition

→ The breast cancer finding was more nuanced than reported — the estrogen-only arm of the study (women without a uterus who took estrogen without progestin) actually showed a non-significant reduction in breast cancer risk; the elevated risk came from the combined estrogen-progestin arm, and specifically from the type of synthetic progestin used — an effect not shared by natural micronized progesterone

What the best current evidence actually shows:

→ For hot flashes and vasomotor symptoms — hormone therapy is the most effective treatment available, significantly more effective than any non-hormonal alternative; no debate on this

→ For urogenital symptoms (GSM) — local va**nal estrogen is the most effective treatment

→ For bones — estrogen prevents menopausal bone loss more effectively than any other available intervention

→ For the heart — timing is everything; estrogen started during perimenopause or within 10 years of menopause in women under 60 appears to reduce cardiovascular risk in multiple studies; estrogen started more than 10 years after menopause in women with already-established vascular changes may not provide the same benefit and may carry risk; this timing dependency — the critical window — is one of the most important and most consistently overlooked aspects of menopause management

→ For the brain — the neuroprotective effect of estrogen appears greatest when started during or shortly after the transition, while the brain's estrogen receptors are still fully responsive; the WHI memory study (which found increased dementia risk with combined HRT in older women) is consistent with this — they were starting too late

→ For breast cancer risk — the absolute risk from estrogen therapy is more modest than most women believe; it is roughly comparable to the risk from drinking a glass of wine nightly or being overweight; in the context of the cardiovascular and bone risks of untreated menopause, the overall risk-benefit picture for most women is considerably more favourable than the post-WHI narrative has allowed them to know

Why the route of delivery matters:

→ Transdermal estradiol (patches, gels, sprays) — absorbed through the skin, bypassing liver metabolism; does not raise clotting factors or increase blood clot risk the way oral estrogen does; preferred by most specialist menopause societies

→ Oral estrogen — passes through the liver first, which alters lipid metabolism and raises clotting risk; still an option for many women but transdermal is preferred

→ Local va**nal estrogen — negligible systemic absorption; safe for virtually all women; ideal for urogenital symptoms when systemic estrogen is not being used or not wanted

→ Micronized progesterone (Utrogestan, Prometrium) — the bioidentical form of progesterone; produces a calming brain compound called allopregnanolone that synthetic progestins do not; significantly better safety profile for breast, heart, and brain than synthetic alternatives; strongly preferred over synthetic progestins

→ Testosterone — low-dose testosterone for women is one of the most evidence-supported and most underused interventions in women's hormonal medicine; improves libido, energy, mood, cognitive function, muscle mass, and bone density; typically given as a gel at roughly 1/10th the male dose

Who is most likely to benefit from HRT:

→ Women with significant menopausal symptoms who are within the critical window — within 10 years of menopause and under 60 — have the most favourable risk-benefit profile
→ Women with premature ovarian insufficiency (menopause before 40) — strongly recommended by virtually all guidance
→ Women who have had both ovaries surgically removed — strong recommendation for HRT until at least the natural age of menopause
→ Women with contraindications (active breast cancer treatment, unexplained va**nal bleeding, severe liver disease) — require careful individual assessment with a specialist

🌿 𝐓𝐇𝐄 𝐍𝐎𝐍-𝐇𝐎𝐑𝐌𝐎𝐍𝐀𝐋 𝐀𝐏𝐏𝐑𝐎𝐀𝐂𝐇 — 𝐖𝐇𝐄𝐍 𝐈𝐓'𝐒 𝐆𝐄𝐍𝐔𝐈𝐍𝐄𝐋𝐘 𝐂𝐎𝐌𝐏𝐑𝐄𝐇𝐄𝐍𝐒𝐈𝐕𝐄
Not every woman wants hormone therapy, and not every woman can use it. A genuinely comprehensive non-hormonal approach — not just a list of supplements — can meaningfully improve quality of life during the transition.

🔵 Nervous system regulation — the most impactful non-hormonal intervention

The hypothalamic thermostat that drives hot flashes is directly stabilised by a well-regulated nervous system. Multiple studies show that practices improving vagal tone and calming the stress system produce meaningful reductions in hot flash frequency and severity.

→ Slow coherent breathing — 10–20 minutes daily of slow, rhythmic breathing (around 5–6 breaths per minute); one of the most direct ways to improve vagal tone and hypothalamic stability
→ Yoga — one of the most consistently evidence-supported non-pharmacological interventions for menopause; improves hot flashes, sleep, mood, and joint pain through combined nervous system, hormonal, and physical mechanisms
→ Mindfulness-based stress reduction (MBSR) — significant evidence for reduced hot flash intensity, improved mood, and better sleep through HPA axis recalibration

🔵 Exercise — non-negotiable

→ Resistance training — the single most important exercise intervention for menopausal women; builds and preserves the muscle mass that estrogen loss erodes; improves insulin sensitivity; reduces visceral fat; supports bone density; produces testosterone and growth hormone; aim for at least 3 sessions weekly

→ Weight-bearing aerobic exercise — walking, running, dancing; supports bone density through mechanical loading; reduces cardiovascular risk; 150 minutes weekly

→ Yoga and flexibility — joint health, pelvic floor support, nervous system regulation

→ Important note: swimming and cycling provide cardiovascular benefits but do not provide the bone-loading stimulus that postmenopausal women specifically need; weight-bearing movement should be a priority

🔵 Nutritional priorities

→ Protein — significantly more important than in younger years; postmenopausal muscle is less responsive to protein, so more is needed to achieve the same effect; aim for 1.2–1.6g per kilogram of body weight daily; animal proteins and whey are most effective

→ Calcium — 1,200mg daily through food; dairy, sardines with bones, canned salmon, kale, broccoli, almonds

→ Vitamin D3 with K2 — target blood levels of 100–150 nmol/L; D3 is required for calcium absorption; K2 (MK-7 form, 100–200mcg) directs calcium to bones rather than soft tissues; the most important duo for bone health in the absence of estrogen

→ Magnesium glycinate (or taurate) — 300–500mg daily; supports bone mineralisation, sleep, the GABA system that calms anxiety, and HPA axis regulation; arguably the most universally important mineral in the menopausal transition

→ Omega-3 fatty acids — 2–3g EPA+DHA daily; reduce neuroinflammation driving cognitive symptoms; reduce hot flash frequency in some studies; protect cardiovascular health; support joints

→ Phytoestrogens — plant compounds that weakly bind estrogen receptors:
- Soy isoflavones — multiple meta-analyses show modest reductions in hot flash frequency (~20–25%); most effective in women with the gut bacteria to convert them to the more potent form called equol; fermented soy (miso, tempeh, natto) is preferable
- Ground flaxseed — 1–2 tablespoons daily; modest hot flash reduction and gut estrogen metabolism support
- Red clover isoflavones — similarly modest but consistent evidence for vasomotor benefit
- Honest caveat: phytoestrogens are not a replacement for estradiol; they do not protect bone density meaningfully; they do not address urogenital symptoms; they are a modest but legitimate addition, not a substitute

→ Creatine monohydrate — 3–5g daily; the most evidence-supported supplement for preserving muscle mass and strength in postmenopausal women; may also independently support cognitive function

→ Collagen peptides — 10–15g daily; supports connective tissue, joint comfort, skin, and bone matrix; take alongside vitamin C for maximum collagen synthesis

→ Boron — 3–6mg daily; reduces calcium loss in urine; supports bone density; may modestly increase estradiol and testosterone in postmenopausal women; anti-inflammatory; inexpensive and underused

→ Blood sugar management — removing refined carbohydrates, eating protein at every meal, and pairing fibre with carbohydrates; the insulin resistance that menopause drives is one of the most consequential long-term health factors and one of the most modifiable

🔵 Botanicals with genuine evidence

→ Black cohosh — the most studied botanical for hot flashes; multiple meta-analyses showing significant reduction in frequency and severity; appears to work through the serotonin system rather than estrogen receptors; generally considered safe for women with hormone-sensitive cancers; 40–80mg daily of standardised extract; allow 4–8 weeks to work

→ Ashwagandha (KSM-66) — 300–600mg daily; reduces cortisol and calms the stress system, which directly stabilises the hypothalamic thermostat; improves sleep quality; broad adaptogenic support for the stressed menopausal transition

→ Sage (Salvia officinalis) — specific evidence for reducing hot flash frequency; 150–280mg of dried sage extract daily; also available as a tea; accessible and well-tolerated

→ Rhodiola rosea — 200–400mg daily; adrenal support; particularly useful for fatigue and cognitive fog in the transition

→ Lion's mane mushroom — 500–1,000mg daily; supports brain-derived growth factors (BDNF and NGF); directly relevant for the cognitive and memory symptoms of menopause

→ Maca (gelatinised) — 3–3.5g daily; preliminary evidence for reduced hot flashes and improved mood; appears to work through the hypothalamus rather than through estrogen receptors

→ St. John's Wort — evidence for mood symptoms in menopause; significant drug interactions (antidepressants, anticoagulants, contraceptives, some chemotherapy agents) — check carefully before using

🔵 Sleep — targeted support

Sleep disruption is one of the most universal and most consequential menopausal symptoms — and it is multifactorial, so it needs multiple approaches:

→ CBT-I (Cognitive Behavioural Therapy for Insomnia) — the most evidence-supported non-drug treatment for chronic insomnia; more effective than sleep medication long-term; particularly useful for the learned wakefulness that develops after months of disrupted nights

→ Magnesium glycinate (or taurate) — 300–400mg before bed

→ Glycine — 3g before bed; gently lowers core temperature at sleep onset

→ Ashwagandha — evening dose; cortisol reduction supports deeper sleep

→ Cooling bedding — cooling mattress toppers, moisture-wicking sheets, cool bedroom temperature; practical, inexpensive, and genuinely effective for reducing nocturnal hot flashes

→ Pelvic floor physiotherapy — for urinary urgency and nighttime waking to urinate; one of the most consistently overlooked and most effective interventions for urogenital menopausal symptoms

🩸 𝐖𝐇𝐀𝐓 𝐓𝐎 𝐓𝐄𝐒𝐓

Hormonal:

→ FSH and LH — FSH above 40 on two tests, 6 weeks apart, after 12 months without a period confirms menopause; useful for confirming perimenopause when the picture is unclear in younger women
→ Estradiol — fluctuates widely in perimenopause; a single reading is rarely informative; useful in context alongside FSH
→ Total and free testosterone — essential when low libido, fatigue, and low vitality are present; low testosterone warrants consideration of therapy
→ DHEA-S — adrenal androgen reserve; declines with age and stress independently of menopause
→ Progesterone (day 21 of cycle) — useful in perimenopause to assess whether ovulation is still occurring; less relevant once periods have stopped

Metabolic and cardiovascular:

→ Fasting insulin and HOMA-IR — the insulin resistance that menopause accelerates
→ Full lipid panel including ApoB and Lp(a) — Lp(a) specifically rises at menopause and is an independent cardiovascular risk marker that most standard panels miss
→ hsCRP — systemic inflammation; elevated levels predict more severe symptoms and greater cardiovascular risk
→ HbA1c — metabolic trajectory
→ Homocysteine — cardiovascular and neurological risk marker; elevated with B vitamin deficiency

Bone:

→ DEXA scan — bone mineral density; recommended at menopause as a baseline and every 2–5 years thereafter depending on risk; the standard for osteoporosis diagnosis
→ FRAX score — fracture risk calculation; combines bone density with clinical risk factors to guide treatment decisions

Thyroid:

→ TSH, free T4, free T3, TPO antibodies — thyroid problems and menopause share many symptoms and frequently intersect; Hashimoto's thyroiditis often declares or worsens at the immune changes of the menopausal transition; comprehensive thyroid assessment is essential, not optional

💚 𝐓𝐇𝐄 𝐃𝐄𝐄𝐏𝐄𝐑 𝐓𝐑𝐔𝐓𝐇
Menopause is not a disease.

But it is also not simply a natural process that should be silently endured, or a spiritual transition to be reframed with gratitude, or a minor inconvenience to be waved away by a rushed practitioner.

It is the most significant hormonal transition of adult life since puberty — one that produces real, measurable, biologically consequential changes in every organ system.

The brain fog is real — it is the brain responding to the withdrawal of a hormone that supported its function for forty years. The bone loss is real — the skeleton has lost the signal that kept bone breakdown in check. The cardiovascular risk is real — the heart has lost the estrogen that protected its blood vessel walls for decades. The va**nal dryness and discomfort are real — those tissues have lost the estrogen that maintained their health and function.

These are not failures. They are the predictable, biologically coherent responses of a body adapting to a major hormonal change — responses that deserve to be understood, taken seriously, and thoughtfully addressed.

Understanding what is actually happening is what allows women to make genuinely informed choices — about hormone therapy, about nutrition and lifestyle, about which symptoms need attention and which will pass, about where the real long-term risks lie and how to address them.

Some women will choose hormone therapy — and properly understood, properly timed, and using the right forms, the evidence supports that choice far more strongly than most women have been allowed to know.

Some will not — by preference or by contraindication — and a genuinely comprehensive non-hormonal approach can meaningfully improve quality of life and modestly address long-term risks even without estrogen.

All of those choices are valid. All of them deserve to be made with full information rather than half-truths, outdated fears, or the dismissal that too many women still encounter when they bring these symptoms to a medical appointment.

And beyond the transition itself — the postmenopausal years, for women who navigate them with adequate support and genuine information, can be years of extraordinary clarity, strength, creativity, and health.

The bone can be maintained. The heart can be protected. The brain can be supported. The muscle can be built. The relationships can deepen. The sense of self can clarify.

Not by denying that the transition is real.

But by understanding it fully — and responding with the intelligence and care it deserves. 🌸🌿

https://m.facebook.com/story.php?story_fbid=122137154852739469&id=61572184084012&mibextid=wwXIfr

🌿 This guide is for educational purposes only and does not constitute medical advice. Menopause management — particularly hormone therapy decisions — requires personalised assessment and discussion with a qualified healthcare practitioner, ideally one with specialist training in menopause medicine.